Key clinical point: A new model for patients with acute leukemia appears to predict the risk of venous thromboembolism.
Major finding: The overall cumulative incidence of venous thromboembolism in the high-risk group was 44.0%, compared with 10.5% in the low-risk group.
Study details: A retrospective study involving 501 patients with acute lymphoblastic leukemia and acute myeloid leukemia.
Disclosures: The study was funded by the Canadian Institutes of Health Research. Dr. Lazo-Langner is an investigator with the Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network.
Lazo-Langner A et al. EHA Congress, Abstract S1642.